Volume 11, Number 3—March 2005
Research
Effect of Regulation and Education on Reptile-associated Salmonellosis
Table 1
Serotype | No. of RAS* patients | No. of non-RAS patients | % of all RAS cases | % of all patients infected in Sweden | Type of reptile (could be >1 reptile/case) |
---|---|---|---|---|---|
Salmonella enterica Serotype Enteritidis | 81 | 2,345 | 23.9 | 3.3 | Turtle (46); tortoise (2); lizard (12); snake (28) |
S. Typhimurium | 30 | 2,056 | 8.9 | 1.4 | Turtle (11); lizard (7); snake (16) |
S. Subspecies III | 30 | 8 | 8.9 | 78.9 | Turtle (5); lizard (5); snake (25) |
S. Subspecies I | 19 | 41 | 5.6 | 31.7 | Turtle (7); lizard (4); snake (8) |
S. Newport | 15 | 100 | 4.4 | 13.0 | Turtle (3); lizard (4); snake (9) |
S. Poona | 15 | 19 | 4.4 | 44.1 | Turtle (9); lizard (1); snake (5) |
S. Saintpaul | 12 | 53 | 3.5 | 18.5 | Turtle (12) |
S. Braenderup | 12 | 30 | 3.5 | 28.6 | Turtle (8); lizard(4) |
S. Stanley | 11 | 147 | 3.2 | 7.0 | Turtle (11) |
S. Muenchen | 10 | 30 | 3.0 | 25.0 | Turtle (4); lizard (1); snake (5) |
S. Java | 9 | 49 | 2.7 | 15.5 | Turtle (5); snake (2); several reptiles (2) |
S. Oranienburg | 6 | 84 | 1.8 | 6.7 | Turtle (2); lizard (3); snake (3) |
S. Litchfield | 6 | 12 | 1.8 | 33.3 | Turtle (6) |
S. Subspecies | 5 | 177 | 1.5 | 2.7 | Turtle (4); lizard (1) |
S. Adelaide | 5 | 33 | 1.5 | 13.2 | Snake (5) |
S. Chester | 5 | 11 | 1.5 | 31.3 | Turtle (2); snake (3) |
S. Bovismorbificans | 4 | 350 | 1.2 | 1.1 | Turtle (3); snake (1) |
S. Hadar | 4 | 140 | 1.2 | 2.8 | Turtle (3); snake (1) |
S. Telelkebir | 4 | 4 | 1.2 | 50.0 | Lizard (2); snake (2) |
S. Montevideo | 3 | 55 | 0.9 | 5.2 | Turtle (2); lizard (1) |
S. Subspecies II | 3 | 12 | 0.9 | 20.0 | Turtle (1); lizard (1) |
S. Subspecies IV | 3 | 2 | 0.9 | 60.0 | Lizard (3) |
S. Infantis | 2 | 324 | 0.6 | 0.6 | Snake (2) |
S. Bredeney | 2 | 56 | 0.6 | 3.4 | Turtle (2) |
S. Heidelberg | 2 | 44 | 0.6 | 4.3 | Turtle (2) |
S. Panama | 2 | 35 | 0.6 | 5.4 | Lizard (1); snake (1) |
S. Abony | 2 | 17 | 0.6 | 10.5 | Turtle (2) |
S. Ituri | 2 | 5 | 0.6 | 28.6 | Snake (2) |
S. Napoli | 2 | 1 | 0.6 | 66.7 | Lizard (1) |
S. Bonn | 2 | 0 | 0.6 | 100.0 | Turtle (1) |
S. Nima | 2 | 0 | 0.6 | 100.0 | Snake (1) |
S. Shubra | 2 | 0 | 0.6 | 100.0 | Turtle (1) |
S. Agona | 1 | 429 | 0.3 | 0.2 | Snake (1) |
S. Virchow | 1 | 152 | 0.3 | 0.7 | Turtle (1) |
S. Thompson | 1 | 54 | 0.3 | 1.8 | Snake (1) |
S. Blockley | 1 | 51 | 0.3 | 1.9 | Lizard (1) |
S. Mikawasima | 1 | 27 | 0.3 | 3.6 | Turtle (1) |
S. Muenster | 1 | 7 | 0.3 | 12.5 | Snake (1) |
S. Oslo | 1 | 3 | 0.3 | 25.0 | Lizard and snake (1) |
S. Reading | 1 | 3 | 0.3 | 25.0 | Snake (1) |
S. Ibadan | 1 | 2 | 0.3 | 33.3 | Snake (1) |
S. Monschaui | 1 | 2 | 0.3 | 33.3 | Snake (1) |
S. Rubislaw | 1 | 2 | 0.3 | 33.3 | Snake (1) |
S. Urbana | 1 | 2 | 0.3 | 33.3 | Turtle (1) |
S. Farmsen | 1 | 1 | 0.3 | 50.0 | Snake (1) |
S. Pomona | 1 | 1 | 0.3 | 50.0 | Turtle (1) |
S. Abaetetuba | 1 | 0 | 0.3 | 100.0 | Turtle and lizard (1) |
S. Lome | 1 | 0 | 0.3 | 100.0 | Snake (1) |
S. Matadi | 1 | 0 | 0.3 | 100.0 | Turtle (1) |
S. Spartel | 1 | 0 | 0.3 | 100.0 | Lizard (1) |
S. Tamberma | 1 | 0 | 0.3 | 100.0 | Snake (1) |
S. Veijle | 1 | 0 | 0.3 | 100.0 | Snake (1) |
S. Windemere | 1 | 0 | 0.3 | 100.0 | Snake (1) |
>1 serotype† | 4 | ‡ | 1.2 | – | Lizard (1); snake (3) |
Not typed | 2 | ‡ | 0.6 | – | Snake (2) |
Total no. of cases | 339 | 6,974 | 100 | 100 | – |
*RAS, reptile-associated case of Salmonella infection, human.
†1 case respectively with S. Adelaide + S. Montevideo, S. Agoueve + S. Chester + S. Infantis, S. Ajiobo + S. Muenchen, and S. Mesbit + S. Montevideo.
‡Not available.
Page created: April 25, 2012
Page updated: April 25, 2012
Page reviewed: April 25, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.